Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Articaine Versus Lidocaine in Supplemental Infiltration for Mandibular First Molars With Symptomatic Irreversible Pulpitis After Failed Inferior Alveolar Nerve Block: A Prospective Randomized Double-Blind Clinical Trial

NCT07869394 is registered in ClinicalTrials.gov with Rehman Medical Institute - RMI as lead sponsor.

NCT NCT07869394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Articaine Versus Lidocaine in Supplemental Infiltration for Mandibular First Molars With Symptomatic Irreversible Pulpitis After Failed Inferior Alveolar Nerve Block: A Prospective Randomized Double-Blind Clinical Trial
Lead sponsor
Rehman Medical Institute - RMI
Phase
Phase 4
Overall status
Completed
Start date
March 3, 2026
Completion date
August 27, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

failed inferior alveolar nerve block, irreversible pulpitis